|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.20 USD | +5.17% |
|
+11.28% | -3.53% |
| 07-01 | Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow | CI |
| 07-01 | Harrow Announces Commercial Launch of BYOOVIZ In The United States | CI |
| Market Cap | 1.67B 1.46B 1.35B 1.24B 2.34B 161B 2.4B 16.12B 6.34B 78.9B 6.28B 6.14B 272B | P/E 2026 * |
180x | P/E 2027 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.67B 1.46B 1.35B 1.24B 2.34B 161B 2.4B 16.12B 6.34B 78.9B 6.28B 6.14B 272B | EV / Sales 2026 * |
4.8x | EV / Sales 2027 * | 3.24x |
| Free-Float |
84.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Harrow, Inc.
| 1 day | +5.23% | ||
| 1 week | +11.28% | ||
| Current month | +11.30% | ||
| 1 month | +12.71% | ||
| 3 months | +13.90% | ||
| 6 months | -0.94% | ||
| Current year | -3.53% |
| 1 week | 40.85 |  | 47.5 |
| 1 month | 40.5 | | 47.5 |
| Current year | 28.54 | | 54.85 |
| 1 year | 28.54 | | 54.85 |
| 3 years | 7.6 | | 59.23 |
| 5 years | 5.4 | | 59.23 |
| 10 years | 1.35 | | 59.23 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 53 | 2011-12-16 |
Andrew Boll
PSD | President | 43 | 2025-08-20 |
Brett Burrell
CMP | Compliance Officer | - | 2023-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Baum
CHM | Chairman | 53 | 2021-08-18 |
Perry Sternberg
BRD | Director/Board Member | 57 | 2022-03-30 |
Adrienne Graves
BRD | Director/Board Member | 71 | 2024-01-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/18/26 | Free | Director | 5,248 | 0.0141% | ||
| 6/18/26 | Free | Director | 5,248 | 0.0141% | ||
| 6/18/26 | Free | Director | 5,248 | 0.0141% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.17% | +11.28% | +30.80% | +162.32% | 1.67B | |
| +0.47% | -1.22% | +54.18% | +162.57% | 1,043B | |
| +0.91% | -1.94% | +54.61% | +58.41% | 602B | |
| +0.38% | +3.13% | +33.67% | +89.75% | 449B | |
| +0.78% | -0.71% | +30.04% | +24.61% | 327B | |
| +1.41% | +0.58% | +33.92% | +47.20% | 279B | |
| -0.27% | -1.87% | +22.13% | +23.47% | 264B | |
| -2.40% | +0.04% | +21.88% | +59.55% | 201B | |
| -1.20% | +3.75% | +23.81% | +73.85% | 169B | |
| -0.62% | +3.66% | +1.93% | -30.13% | 143B | |
| Average | +0.41% | -0.16% | +30.70% | +67.16% | 347.87B | |
| Weighted average by Cap. | +0.25% | -1.81% | +39.77% | +84.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 348M 305M 281M 259M 488M 33.56B 499M 3.36B 1.32B 16.43B 1.31B 1.28B 56.57B | 516M 451M 416M 383M 722M 49.66B 738M 4.97B 1.95B 24.32B 1.94B 1.89B 83.72B |
| Net income | 9.81M 8.57M 7.91M 7.29M 13.74M 945M 14.05M 94.56M 37.19M 463M 36.84M 36.03M 1.59B | 92.93M 81.21M 74.94M 69.07M 130M 8.95B 133M 896M 352M 4.38B 349M 341M 15.09B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | US$47.21 | +5.19% | 410,450 |
| 26-07-16 | US$44.88 | +4.54% | 934,505 |
| 26-07-15 | US$42.93 | +3.77% | 501,135 |
| 26-07-14 | US$41.37 | -1.05% | 309,095 |
| 26-07-13 | US$41.81 | -1.58% | 289,307 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HROW Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
